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Abstract 
The study discusses the Coronavirus (COVID-19) in context. By its nature, the Coronavirus (or COVID-19) is a 
respiratory disease caused by a novel (new) coronavirus, which was first detected in China but subsequently 
detected in almost 70 geographical locations internationally. The pandemic nature of COVID-19 has caused many 
countries, including the United States of America, to embark on stringent health measures. Consequently, all 
affected countries have utilized such preventive measures as travel restrictions, official and self quarantines, event 
postponements as well as cancellations, curfews and facility closures. In order to assist policymakers to combat 
this pandemic, my study has utilized the concept of epidemiology to assist all stakeholders to have a better 
understanding of the epidemiological concept of coronavirus (or COVID-19) and its possible eradication measures. 
Furthermore, the study strongly recommends that, for successful eradication to be effected, all COVID-19 
preventive care must be free (or demand at a zero price), while COVID-19 treatment (or medication) must also be 
either free or at a subsidized rate and COVID-19 screening must be motivational for individuals to buy into the 
idea through public campaigns and, also, there should be adequate information flow about the COVID-19 and its 
prevalence rate. Above all, governmental or   public interventions must outweigh private intervention measures in 
order to make COVID-19 eradication possible. 
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INTRODUCTION 
According to the available health and medical  literature, Coronavirus (COVID-19)  is a respiratory disease 
caused by a novel (new) coronavirus that was first detected in China but  has now been detected in almost 70 
geographic locations internationally, including  the United States of America (Centers for Disease Control and 
Prevention, 2020). According to Centers for Disease Control and Prevention (2020), the virus has been named 
“SARS-CoV-2” and the disease it causes has been named as “coronavirus disease 2019” (abbreviated as “COVID-
19”).  On black Thursday (January 30, 2020), the International Health Regulations Emergency Committee of the 
World Health Organization (WHO) declared the COVID-19 outbreak as a “public health emergency of 
international concern external icon” (PHEIC) (CDC, 2020).  The CDC (2020) further argued that on January 31, 
2020, Health and Human Services Secretary Alex M. Azar II declared a public health emergency (PHE) for the 
United States in order to aid the nation’s healthcare community in responding to COVID-19. 
Historically, the argument of  medical experts as well as academia and health literature is that coronaviruses 
are part of a large family of viruses, which  are common in humans and many different species of animals and 
other  non-humans, including camels, cattle, cats, bats and many others (CDC, 2020). Meanwhile, medical e and 
health practitioners have proven, in the available literature, that non-human (or animal) coronaviruses can infect 
humans  and subsequently  spread among  people such as with the conventional viruses with MERS-CoV, SARS-
CoV, and, now, with this new virus (named as SARS-CoV-2 or COVID-19) (CDC, 2020). 
 According to CDC (2020), the SARS-CoV-2 virus is a betacoronavirus, which can spread and infect 
people like MERS-CoV and SARS-CoV.  Surprisingly, all such types of viruses as SARS-CoV-2 or COVID-19, 
MERS-CoV and SARS-CoV have their origins in bats (CDC, 2020). Therefore, it has been alleged in numerous 
reports that many of the patients at the epicenter of the outbreak in Wuhan, Hubei Province, China had some link 
to a large seafood and live animal markets, thereby suggesting that animal-to-person spreading of the virus is 
possible (CDC, 2020). It has also been observed by several citizens and physicians that a growing number of 
patients also did not have exposure to animal markets, indicating person-to-person spread of the virus (CDC, 
2020).  
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 Person-to-person spread of the virus was subsequently reported outside Hubei and in countries outside 
China, including in the United States of America, Italy, and many other countries. Some international destinations 
now have apparent communities spreading the virus that causes COVID-19, including in some parts of the United 
States (CDC, 2020). According to the epidemiological concept of the spread of diseases, being it viral or bacterial 
infectious diseases, a community spreading of the virus simply means that some people have been infected and it 
is not known how or where they became exposed to the disease. At this point,   the susceptible individuals are 
exposed to the diseases, and they later get actively infected. 
 
Figure 1: COVID-19 Pandemic Statistics 
According to Huang et al.(2020), the 2019–20 coronavirus pandemic is an ongoing situation of 
coronavirus disease of 2019 (COVID-19), which is caused by severe acute respiratory syndrome, thus coronavirus 
2 (SARS-CoV-2). The outbreak was first identified in Wuhan  and Hubei in China in December of 2019, and it 
was recognized as a pandemic by the World Health Organization (WHO) on 11th March 2020 (Huang et al., 2020; 
Worldometer, 2020; World Health Organization, 2020). As of 25th March 2019 it was reported that more than 
422,000 cases of COVID-19 had have been reported in more than 190 countries and territories, resulting in more 
than 18,900 deaths and more than 109,000 recovered patients  (Huang et al., 2020; Worldometer, 2020; World 
Health Organization, 2020).  
In the literature, the World Health Organization (2020) and Centers for Disease Control and Prevention 
(2020) concurrently have the argument that the virus is typically spreading during close contact and through 
respiratory droplets produced when people cough or sneeze. Whenever an infected person coughs or sneezes, it 
increases the prevalence and hazardous rate. Therefore, the respiratory droplets may be produced during breathing 
but it is not considered airborne (World Health Organization, 2020). Meanwhile, theses two agencies further 
argued that the COVID-19 may also spread when one touches a contaminated surface and then touches their face 
(World Health Organization, 2020; Centers for Disease Control and Prevention, 2020). It is most contagious when 
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people are symptomatic, although spread may be possible before symptoms appear (Centers for Disease Control 
and Prevention, 2020).  It has also been observed in the literature that the time between exposure and symptom 
onset is typically around five days, but may range from two to fourteen days (Centers for Disease Control and 
Prevention, 2020; Rothan and Byrareddy, 2020).  
 The fourteen- day period is also known as the incubation period for COVID-19. The Centers for Disease 
Control and Prevention (2020) further argued that the obvious or most common symptoms for identifying a 
COVID-19 patient or infection include fever, cough, and shortness of breath. They have further indicated that the 
complications may include pneumonia and acute respiratory distress syndrome (Centers for Disease Control and 
Prevention, 2020). Currently, it is obvious that there is no known vaccine or specific antiviral treatment. As a 
result, it has been proposed by the numerous healthcare providers that the primary treatment is symptomatic and 
supportive therapy (Centers for Disease Control and Prevention, 2020). Also,  recommended preventive measures 
include hand washing, covering the mouth when coughing, maintaining distance from other people, and 
monitoring and self-isolation for people, who suspect that they are infected (World Health Organization, 2020; 
Centers for Disease Control and Prevention, 2020).  
The pandemic nature of COVID-19 has caused many countries to embark on stringent measures. All 
affected countries have utilized efforts to prevent the spreading of the virus to include travel restrictions, 
quarantines, curfews, event postponements and cancellations, self-isolation, and facility closures. These have  
included  the  quarantine of Hubei, nationwide quarantines in Italy, quarantine in USA, quarantine in Ghana, 
elsewhere in Europe, Africa and in India, curfew measures elsewhere in China, Ghana and South Korea (South 
China’s Morning Post, 2020; Marsh, 2020; Nikel, 2020);  various border closures or incoming passenger 
restrictions (The Straits Times, 2020; Nevada Public Radio, 2020); screening at airports and train stations (South 
China Morning Post, 2020; Marsh, 2020; Nikel, 2020;The Straits Times, 2020; Nevada Public Radio, 2020; 
Deerwester and Gilbertson,2020; The New York Times, 2020);  and travel advisories regarding regions with 
community transmission (Deerwester and Gilbertson, 2020; The NewYork Times, 2020; The Government of the 
United Kingdom, 2020; UNESCO, 2020); Schools and universities have closed either on a nationwide or local 
basis in more than 124 countries, affecting more than 1.2 billion students across the globe (The New York Times, 
2020).  
The pandemic has led to global socio-economic disruption (The NewYork Times, 2020),  the 
postponement or cancellation of sporting, religious, and cultural events (The NewYork Times, 2020; Scipioni, 
2020), and widespread fears of supply shortages which have spurred panic buying (Scipioni, 2020;Council on 
Foreign Relations, 2020; Misinformation and conspiracy theories about the virus have spread online (Perper, 2020; 
Clamp, 2020), and there have been incidents of xenophobia and racism against Chinese and other East or Southeast 
Asian people (Tavernise, Oppel, and Richard, 2020). This current study is to assist public policymakers, politicians 
and academia as well as health care practitioners to better understand the epidemiological concept of corona virus 
(or COVID-19) and its eradication measures. 
COVID-19 United States of America in the Context 
Currently, the number of infected people is increasing everyday in the United States of America.  Meanwhile, all 
the COVID-19 cases recorded in USA are imported cases of COVID-19 in travelers. Readers should note that the 
person-to-person spread of COVID-19 was first reported among close contacts of returned travelers from Wuhan 
in China (Centers of Disease Control and Prevention, 2020). During the week of February 23, 2020-- the CDC 
reported community spread of the virus that causes COVID-19 in California (in two places), to include Oregon 
and Washington States. The community spread in Washington resulted in the first death in the United States from 
COVID-19, as well as the first reported case of COVID-19 in a health care worker, and the first potential outbreak 
in a long-term care facility (Centers of Disease Control and Prevention, 2020).  
 In fact, the foregoing reported community spread of COVID-19 in parts of the United States raises the 
level of concern about the immediate threat for COVID-19 for those communities and other susceptible states. 
According to the Centers of Disease Control and Prevention (2020) the potential public health threat posed by 
COVID-19 is very high, to the United States and globally. In the absence of vaccination and remedial actions to 
combat this current pandemic COVID-19 deadly disease—the epidemiological concept of COVID-19 in United 
States of America has therefore increased from 80 confirmed cases of COVID-19 and 9 deaths as at January 12, 
2020 to 60, 054 confirmed cases of COVID-19, 380 recovery, and 804 deaths as of March 25, 2020 (Centers of 
Disease Control and Prevention, 2020). 
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Figure 2: Currently Testing States and States in Progress (CDC, 2020) 
Figure 2 reveals the states that have successfully verified and are currently using COVID-19 diagnostic tests. These 
states are currently testing for COVID-19 with the enabling help and support from the Association of Public Health 
Laboratories (APHL).   
 
Figure 3: US COVID- 19 Cases as at March 25, 2020 23: 25:05 UTC+7 (Virusncov.com) 
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Figure 3 discusses the US COVID-19 cases as at March 25, 2020. According to the Virusncov.com (2020) the 
total cases of COVID-19 per 1 million populations is 181.6. This implies that given the entire American population 
of 330.43million as at March 25, 2020—on average, every 1 million people will have 181.6 people to be infected 
with the COVID-19, which -- in effect-- increases the hazardous and prevalence rate of the spread of COVID-19 
disease in the country. This alarming rate motivated the researcher to conduct this particular study to better inform 
public policymakers on the epidemiological concept of COVID-19 in USA.  
2. MODELING: EPIDEMIOLOGICAL CONCEPT OF CORONAVIRUS (COVID-19) 
According to health and epidemiology literature, the term epidemiology is about the spread of diseases and how 
different policies can be used to prevent such diseases (Folland, Goodman, & Stano, 2004; Phillison, 2000; Adu-
Frimpong, 2016). There are several principles, terminologies or concepts, which have utilized to explain the 
epidemiological concepts of COVID-19 to include the hazard rate, incidence rate, and prevalence rate. It is very 
important to know how disease spread. The author (Adu-Frimpong, 2016), hazardous rate refers to the probability 
of an individual getting the disease (COVID-19) or the rate of new cases (of COVID-19) among the uninfected 
population in a given period of time (Folland, Goodman, & Stano, 2004; Phillison, 2000; Adu-Frimpong, 2016). 
Also, incidence rate has been defined in the literature to refer to as the number of new cases of COVID-19 per 
defined population (USA citizens). The concept of prevalence rate is also defined in the literature to refer to as the 
fraction of those who has the disease of COVID-19 or the fraction of population that is currently infected by the 
COVID-19 disease (Folland, Goodman, & Stano, 2004; Phillison, 2000; Adu-Frimpong, 2016). It is to mention 
that there is a positive relationship between incidence and prevalence rates. Meanwhile, by assumption it is 
important to note that increase in prevalence rates falls as people develop immunity or adaptive behaviors (Folland, 
Goodman, & Stano, 2004; Phillison, 2000; Adu-Frimpong, 2016). 
2.1 Predictions of the Spread of COVID-19 Disease in United States of America 
 At this juncture, the researcher discusses the things that scholars chave based on to predict the 
spreading and the extent of eradicating the diseases among a given population over a period of time to include 
both the private and the public intervention (see Figure 4 for details). For the case of private intervention, it is 
assumed to include the following: (a) the behavior of rational epidemics, (b) implications for private disease 
eradication, (c) the rational disease dynamic of epidemics, and (d) the positive effects of prevalence on assortative 
matching (Folland, Goodman, & Stano, 2004; Phillison, 2000; Adu-Frimpong, 2016). Meanwhile, the rational 
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epidemics and public health intervention includes the public price subsidies, mandatory vaccination and the public 
intervention into allocation of information are also equally critical to the prevention of the outbreak. 
 The Behavior of Rational Epidemic—it is part of the private intervention. It is micro-level 
strategy or methods to delay the outbreak or decompress the spread of the disease overtime. The following 
assumptions are used to model the behavior of the citizens or individuals. To better inform policymakers, the 
model assumes four classes of peoples according to health at time t (or year 2020) and they are as follow: St= 
Susceptible (those without the COVID-19 disease but likely to get); It= COVID-19 Infected people or group or 
prevalent rate; R t= Immune peoples through recovery (immune after recovery from COVID-19) ; Mt= Mortality 
resulting from COVID-19 (those outside the system). The researcher further assumes the condition of the 
normalization of the American population to unity (or one).  Again, the researcher assumes the future paths of the 
groups to be: (a) Prevalence: It= { Is: s ≥t}; and Price: Pt= { Ps: s ≥t}.  The model further assumes instantaneous 
demand for vaccine or preventive care for COVID-19 at time t  (or year 2020) on the two such paths are D(It ,Pt); 
where the demand for vaccine or preventive care depends on the prevalence rate and the price level at time t i.e.  
D= f (prevalence rate, price of vaccine, e.t.c.) 
As a result the model further assumes that: b= Birth rate into the United States of America; m=Mortality rates out 
of the system or USA; w=Natural withdrawal rate from COVID-19 infection to immunity; and β=Probability of 
infection rate (hazard rate) due to COVID-19.    
Therefore, the changes over time in the health status of the American citizens based on the assumptions are as 
follows; 
 

 = b[1-D(It , Pt)] - β It St - m St ………………………………………………… (1) 
Thus changes in the fraction of susceptible individuals or citizens over time   depends on the entry of newborns 
who do not vaccine or take preventive care or precautions (b [1-D (It , Pt)]). But exit or mortality is due to new 
infections of COVID-19 (β It St) and non-COVID-19 disease related such as accident, flu, diabetics, e.t.c. (mSt).  

 = β It St – (w + m)It …………………………………………………………… (2a) 
The equation (2) can be expanded to be written as 
 

  = β It St – wIt - mIt …………………………………………………………… (2b) 
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In fact, both equations (2a & 2b) elucidate that the changes in COVID-19 prevalence rate over time   which is 
due to entry of new infection gotten through the violation of the preventive precautions—that is refusing to use 
the hand sanitizers, face-mask, social-distancing e.t.c. (β It St) and exits (or die) due to COVID-19  immunity (wIt) 
and infection related mortality (mIt). Here the new COVID-19 infection (β It St) is due to the interaction between 
the susceptible (St) and the infected (It) under random matching (that is refusing to obey the social distancing 
regulations or violating the other COVID-19 preventive care measures). 
 

  = b[D(It, Pt)] + wIt  - mRt ……………………………………………………  (3) 
Very importantly, the equation (3) also explains the changes in the fraction of the Americans’ population that is 
immune   which is due to new born who vaccinates or have purchased and used COVID-19 preventive care 
(b[D(It, Pt)]) and those recovering from infection of COVID-19 through proper care by healthcare practitioners’ 
(wIt) as well as those who exit (or die) through non-disease related (mRt). To better assist policymakers, 
bureaucrats, and politicians to understand the growth or the spread of the COVID-19 equation 4 was as well 
utilized.  

  ≥ 0                                             


 β St ≥ 1…………………………………………. (4) 
Here β St represents the rate of the susceptible who come into contact with the COVID-19 infected person, 


  
also represents the average time of infection and the equation (4) implies that, for infection to grow the infected 
individual should at least infect more than one individual before he/she exit (or die) from the infected population. 
That is why the self-quarantine or containment methods and other preventive care measures have been utilized to 
minimize the growth of the COVID-19 infection.  
  ρ=  

  ………………….………………………………………….…………………. (5) 
The equation (5) represents the secondary infection generated by a single new infection of COVID-19 (or COVID-
19 case) when the entire American population or citizens are all susceptible. Thus the disease can take over this 
population only when the ratio is greater than one (1) as shown in equation (4) above. 
Understanding the Implications for Private Disease Eradication—another important tool used to fight 
epidemic is vaccination or preventive care measures. In fact, with the exception of smallpox, vaccination has not 
been able to eradicate diseases. Now the question is: how do rational agents (infected and uninfected) behave in 
the face of epidemic or COVID-19? 
It is expected that the susceptible rational individuals will demand preventive care in the face of an epidemic like 
COVID-19. The amount demanded and hence the ability of the private market to achieve eradication for COVID-
19 is determined by the prevalence elasticity of demand for prevention.  If the elasticity is low, only a small amount 
of prevention will be demanded resulting in higher future prevalence. A large elasticity then leads to a greater 
demand for preventive care for COVID-19 and a lower prevalence in future. Thus when the elasticity is sufficiently 
large, it can lead to a decline in the prevalence rate and slow down the progress of the epidemic in order to flatten 
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the curve (as shown Figure 3). Also, if the demand for prevention is prevalence dependent, then for a positive 
price, demand for prevention goes close to zero for low levels of prevalence. Thus, if demand for vaccine (or 
preventive care) is prevalence dependent then as prevalence falls demand also goes close to zero. However, this 
increases the susceptibility of the population. As a result an infection can regenerate itself in the long-run (i.e. ρ≥I), 
for prevalence to increase again, making eradication impossible. This argument holds as long as price is positive. 
This implies that the COVID-19 disease cannot be eradicated regardless of the market structure (i.e., whether it is 
a monopoly or a perfect competitive market). Thus the difficulty of eradication comes from the demands side 
rather than the supply side of the market. 
Understanding the Concept of Rational Disease Dynamics of Epidemics 
Let assume the consumer of COVID-19 preventive care’s utility function to be U (h, d) over a binary demand for 
protection. Where “d” represents the demand for protection or preventive care which is binary (Yes or No) and 
“h” also represents the healthy state whether susceptible (s) or infected state (i). Therefore the value function of 
the health state is given as in equation (6) and this value function is used to investigate into the demand for 
preventive care.  
V(s) = max {U(s, 1) + α V(s), U(s, 0) + α[ β It V (i) + (1- β It) V (s)]}………………… (6)   
Where; α represents discount factor (rate), β represents hazard rate, U(s, 1) represents utility with COVID-19 
vaccination (i.e. with preventive care), αV(s) represents utility in the future period when the individual vaccinate 
{i.e. have preventive care or (with no infection)}, U(s, 0) represents utility with no COVID-19 vaccination (i.e. 
have no preventive care) in the current period and α[ β It V (i) + (1- β It) V (s)] represents the utility in the future 
period with no vaccination (i.e. no preventive care). The utility with no COVID-19 vaccination can be attributed 
to the probability of infection, if you do not vaccinate (β It V (i)) and no infection when you do vaccinate [(1- β It) 
V (s)].    
The equation (6) means that, a continual protection in the current period implies susceptibility in the future but no 
protection leads to an increase in the probability of being infected and this probability increases with prevalence. 
The equation (6) can be maneuvered for further analysis as shown below to arrived at equation (7), by subtracting 
the vaccination state from no vaccination state; 
U(s, 0) - U(s, 1) = α[ β It V (i) + (1- β It) V (s)] - αV(s) 
U(s, 0) - U(s, 1) = α β It V (i) + α V (s)] - α β It V (s) - αV(s) 
U(s, 0) - U(s, 1) = α β It V (i) - α β It V (s)  
U(s, 0) - U(s, 1) ≥ α β It [V (i) - α V (s)] ….……………………………………………… (7) 
The equation (7) implies that the individual will remain exposing to the disease as long as the benefit exceeds the 
cost in the future due to the risk of infection. It is further assume that here the individual engages in protection 
after the reservation prevalence (K), has been reached. The reservation prevalence satisfies K as shown below; 
d=0,  It ≤ K ≡ 
[(,
)  (,) ]
[(,
)  (,) ]  ……………………………………………….………….. (8) 
Public Policy and Administration Research                                                                                                                                       www.iiste.org 
ISSN 2224-5731(Paper) ISSN 2225-0972(Online)  
Vol.10, No.3, 2020 
 
69 
The equation (8) represents the threshold prevalence, below which there is no protection for COVID-19 but above 
it there is protections for COVID-19 (It ≤ K). The threshold prevalence rises with the discount factor or rate (α) 
and the cost of COVID-19 protection [U(s, 1)], falls with the cost of infection [U(s, 0)] and the probability of 
transmission given the exposure or the hazard rate (β). Assume also a close population (a population without social 
distancing) and the reservation prevalence levels are distributed according to the cumulative density function F 
(K). Then the epidemic begins with prevalence level I(K, 0) in the population and takes off by infecting those with 
no protection and not yet infected as shown in equation (9) and (10).  
Io= ʃ I(K, 0)dF…………………………………………………………………………… (9) 
It = β It Qt G(It) ………………………………………………………………………… (10) 
G (It) = ʃ[1- I(K, 0)]dF…………………………………… ……………………… (11)    
Where equation (11) is part of the population that are susceptible and choose to engage in transmissive activity at 
prevalence It and Qt= exp [- ʃ  β Is ds] is the fraction of those not yet infected with COVID-19 despite exposure to 
infection. 
 
Figure 4: Flattening the Curve through Resource Allocation to Minimize Prevalence and Hazard Rate. (Source: 
Noreen Qualls, Alexandra Levitt and Co-authors, 2020). 
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 According to Noreen Qualls, Alexandra Levitt and co-authors (2020), the goal of every 
community mitigation methods in the midst of pandemic include the following: (1) delay outbreak peak (2) 
decompress peak burden on healthcare, known as flattening the curve and (3) diminish overall cases, and health 
impact (see Figure 4 for more details). Meanwhile, G in the model shows the behavioral response of population to 
growth in prevalence (that is either to delay the outbreak or decompress peak burden). If the elasticity of prevalence 
is low or response is exogenous in the model (as in epidemiological models) then a change in prevalence will not 
affect protection behavior which are more likely to decompress the peak to diminish the overall cases and its 
associated health impact. Since the hazard rate tends to increase in the prevalence rate. Therefore, as the prevalence 
increases, the probability of susceptible individual and getting infected increases. That is why   more people get 
infected in the next period thereby heading to the peak of the curve. It is important for readers, policymakers, 
politicians to note that the elasticity of prevalence determines the epidemic behavior of the outbreak of COVID-
19 diseases. However, when G is allowed to vary then, it is possible for the hazard rate to be a decreasing function 
of prevalence due to a resulting increase in protective behavior. Thus the share of population that becomes infected 
falls even though more and more people become infected thereby flattens the curve. As the elasticity of prevalence 
gets larger and larger the hazard becomes a decreasing function of prevalence. The elasticity has to be larger, the 
larger the prevalence to ensure the counteractive positive effect (increasing in protective behavior) is more 
pronounced. 
3. THEORETICAL APPROACHES OF ANALYZING THE BUDGETARY ALLOCATION OF A 
NATION’S RESOURCES TO TACKLE PANDEMIC BY STAKEHOLDERS: A CASE OF 
CORONAVIRUS (COVID-19)-GLOBAL CRISIS 
 
As a fact, there exists a positive relationship between healthcare and health status (Adu-Frimpong, 2016; 
Grossman, 2010). But the relationship is subject to the law of diminishing marginal utility. This is because the 
individual do not desire (or crave) for healthcare. In actuality no one desire to do surgery, or take injection, 
vaccination, immunization, or buy wheel-chair—unless he/she is not feeling good or sick. Therefore, the desire 
for a person to feel good (or fine) then motivate them to invest into their health by either exercising more or taking 
in more drugs (medication). When one speaks of health and the provision of healthcare Practitioners are very 
central in healthcare market in terms of decision making because they determines the quantity level of healthcare 
to be consumed by patients and the kind of drug that is good for individual’s consumption to maintain and improve 
upon the well-being of an individual. Meanwhile, the Health Economist is always interested in the efficient 
allocation of the nation’s resources towards the healthcare financing to make available healthcare goods, for the 
individual consumption at the optimal level to improve and maintain the well-being of the human system. 
When it comes to the entire budgetary allocation politicians and the bureaucrats play a key role in the 
decision making processes. In relation to the bureaucrats role in decision making process—the health economist 
advises the public policymakers or decision makers to ensure an efficient allocation of the nation’s resources at a 
point where the marginal benefit derived from the individual is equal to the marginal cost incur on the treatment 
of the individuals in a given population (Adu-Frimpong, 2016). However, there has been series of conflicting 
theme between politicians and healthcare providers. The relationship between the healthcare decision by health 
practitioner and the health economist (or politicians) is view and explain from; Kink curve, Optimal upward 
sloping curve, the flat of the curve and the curve with the peak (Adu-Frimpong, 2016). 
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Figure 5: The Kink Curve                         
 
Figure 5 reveals the relationship between healthcare consumption and health status of a given population. 
Taking for the case of COVID-19, under Kink of the curve, theoretically the health practitioners will argue that 
the politicians should make available the funds to finance health care goods of the people such as free testing, 
treatment, protective measures, e.t.c as long as they improve the health status of the individuals. They believe that 
as long as healthcare i.e. medication or drugs improves the health of the person until it gets to N* continue to give 
it them. To the health practitioner the optimal point of healthcare consumption is the N*.  However, the health 
economist will advise the politicians to compare the cost of producing the healthcare to that of the benefit the 
society will derive from the treatment of the outbreak. If the healthcare cost is very cheap relative to the benefit 
then, the health economist will agree to the usage of the nation’s resources for healthcare production to make 
available for the treatment to the sick to improve upon their health status. Therefore the health economist will 
agree to the consumption of the healthcare until a point where the marginal cost is equal to the marginal benefit 
(Adu-Frimpong, 2016). But if the marginal cost is lower than the optimal healthcare in-take (N*), then 
consumption could continue until it gets to the optimal point (N*). Because the COVID-19 is a pandemic and 
benefit for treating this outbreak outweighs the cost, pain, and fears instill in the citizens, the politicians, healthcare 
practitioners, and health economists will agree to release funds to finance the outbreak. As result the relationship 
between health care consumption and improvement in the health status of the citizen will be expected to an upward 
sloping curve (see Figure 2 for more details).  
  
Public Policy and Administration Research                                                                                                                                       www.iiste.org 
ISSN 2224-5731(Paper) ISSN 2225-0972(Online)  
Vol.10, No.3, 2020 
 
72 
                   HS  
 
 
 
 
                                                                                                        HC 
                          Figure 6: Optimal Upward Sloping Curve 
Figure 6 reveals that all the stakeholders—politicians, health economists, and health practitioners will agree for 
testing kits, medication, treatment, and many other measures to be available to the citizens. All of the stakeholders 
will agree to the fact that the individual needs healthcare (HC) in order to improve on their health status. As a 
result they will all agree to release funds in order to permit the citizens to consume healthcare (HC) as long as 
healthcare is a normal good that improves the health status (HS) of the citizens. Here before the person gets to the 
optimal level a lot of resources would have been wasted by the health practitioner due to try and error in order to 
identify the right prescription for the patient. This is a typical case of the first phases of an outbreak where a quick 
solution or response is needed to assist the patients or the infected ones. At this stage there is no right or wrong 
approach to treatment as long as the method help to minimize the spread of the outbreak and also help the sick 
ones to recover, cases in point are Ebola, and COVID-19. This process in the longer flattens the curve of the 
upward sloping curve (see Figure 4 for more details). 
                  HS             no kink or optimal level 
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                           Figure 7: Flat of the Curve 
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Figure 7 discusses the flat of the curve—which reveals that in the face of a pandemic or virulent disease as COVID-
19 there is no optimal level of health care consumption to prevent, treats, and minimize the spread of the outbreak 
in the short-run.  This is because one key feature of the flat of the curve is that there is no optimal level or point 
for the consumption of healthcare by the health practitioner or the health economist as well as politicians. Above 
all, in relation to the nature of the diagram, the infected ones have to consumed medication or healthcare 
unnecessary—as a result there will be a great depletion of the nation’s resource since all the stakeholders 
(politicians, policymakers, healthcare practitioners, health economists, citizens e.t.c) do not know the optimal level 
of healthcare consumption.  
          Meanwhile, a typical example in relationship to the flat of the curve analysis is associated with the 
treatment of standard malaria, Ebola, and COVID-19. In treating standard malaria patients, it is difficult to know 
the optimal level of medication needed or healthcare in-take to treat such sicknesses (Adu-Frimpong, 2016). So 
the health economist, politicians, citizens, and other bureaucrats will have the same opinion to the health 
practitioner’s means of treatment. Therefore the health practitioner will agree to the try and error process of 
treatment to aid in eradication of the sickness. The health practitioner will continue giving the medication until 
they realize that the infected ones have been fully recovered. 
4. MEASURES TO CONTROL AND PREVENT COVID-19 FOR SPREADING 
 It is obvious across the globe that almost all countries across the globe or the world are at a shut-
down and in quarantine. Even though these initial approaches are very important to the benefit of the citizens, 
policymakers, healthcare economists, and practitioners in general.  There are a number of strategies in the control 
of the COVID-19 outbreak: containment, mitigation, and suppression. Containment is undertaken in the early 
stages of the outbreak and aims to trace and isolate those infected as well as other measures of infection control 
and vaccinations to stop the disease from spreading to the rest of the population. When it is no longer possible to 
contain the spread of the disease, efforts then move to the mitigation stage, when measures are taken to slow the 
spread and mitigate its effects on the health care system and society. All these measures take into accounts the use 
of hand sanitizers, wearing of face- mask, and using protective clothe as well as regular washing of hands with 
soap or detergents are all equally important to the procedures of controlling the spread of the COVID-19 or the 
virulent disease (coronavirus). Meanwhile, giving the political will of the governing bodies, policymakers, 
lawmakers, and other stakeholders, the under-listed measures if well implemented by the stakeholders will help 
eradicate the outbreak.  
 The study recommends a Mandatory Vaccination for All Residents (Not Only Citizens).  
The expansion of a national healthcare insurance, including a Medicaid program, to cover the treatment of COVID-
19 by law will help eradicate the pandemic in USA. The stakeholder should make a law for every resident to take 
COVID-19 shot or vaccination. The vaccination should be mandatory because the total demand for vaccination 
has two major components which include the mandatory demand in the program (i.e. Medicaid) and the private 
demand outside the program (insurance). The mandatory demand can crowd out private demand such that; there 
exist individuals who would vaccinate in the absence of the program but would not do so in its presence. Thus 
increasing the public coverage has two effects on demand. First it leads to an increase in vaccination as those who 
otherwise would vaccinate do so. Second it reduces demand by those not covered by the program (insurance or 
Medicaid). The second effect, which has a negative effect on the program, becomes larger, and therefore leads to 
larger prevalence elasticity. The increase in demand by those covered by the program reduces prevalence and 
hazard rate and so decreases demand for protective behavior by those not covered by the program. 
 The study further recommends public intervention into the allocation of information. In 
the case of COVID-19, the dissemination of information through screening, community awareness, partner 
notification, education and confidentiality reporting is a widespread public intervention. What is the effect of 
such allocation of information? The information structure of a disease determines its growth and prevalence. 
Also, in a case of a virulent disease like COVID-19, it can be regarded as imperfect information, since an infected 
person may not exhibit any symptoms of the disease until 14 days after the incubation period. Such asymmetric 
information problem, shown in trade models limits the volume of trade. Applying this to COVID-19 pandemic, it 
implies that, people with no infection may practice social distancing, using hand sanitizers, regular washing of 
hands and so would not engage in public gatherings for the fear of infection. For such a case, the health status of 
individuals is revealed through screening.  
 Indeed, the growth of the disease is likely to be lower or get to zero under perfect information. 
Studies on the private demand for information and public subsidies on information acquisition show that, the only 
individual that is likely to alter his/her behavior as a result of the acquisition of information are the low-risk HIV-
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positive and the high-risk HIV-negative. The overall effect of the screening program is likely to be small because 
they offset each other. Empirical studies show that when the low-risk HIV-positive receives private information 
of their HIV status, it had little effect on their behavior. The high-risk HIV-negative individuals however were 
likely to increase the volume of sexual contact. Therefore if education programs target high risk groups, they do 
not lead to a favorable alteration of behavior. A public testing program can have unintended consequences when 
focused on high risk. Susceptible people are however likely to improve their chances of not being infected if they 
learn effective ways to avoid infection. 
 The study further recommends public price subsidy on all the COVID-19 protective tools or 
equipments.  The public price subsidy is the application of the pigouvian subsidy theory. When the prevalence 
elasticity is taken into account, then the long supported pigouvian subsidy for vaccination cannot be effective in 
eradicating an epidemic disease due to low price elasticity in the prevalence responsive models for the case of 
COVID-19 pandemic. Under this model, an increase in the price of vaccination (preventive care—such as 
vaccination or gloves, sanitizers, face-masks, e.t.c) for eradicating, for example has two effects. First, it reduces 
the demand for vaccination which leads to an increase in prevalence. Second, the increase in the prevalence causes 
demand for preventive care (vaccination or gloves, sanitizers, face-masks e.t.c.) to increase. But the total 
counteracting effect of an increased in price of preventive care (vaccination, gloves, sanitizers, face-masks e.t.c) 
falls with the prevalence elasticity. Let’s also consider the application of the pigouvian subsidy as a mechanism 
for eradication. Where the rate of subsidy depends on the prevalence rate, therefore let s (I) represent public 
subsidy. If s(I) >0, then the public subsidy is pro-cyclical and if s(I)<0, then it is counter-cyclical. However, in 
the real-world it is likely for subsidy to be pro-cyclical than the counter-cyclical. An increase in subsidy reduces 
price and the larger the prevalence elasticity the lower the equilibrium I, therefore the pro-cyclical subsidies are 
more likely to lower the equilibrium I, than a counter-cyclical subsidy.  
Conclusion: 
 In a perfectly competitive market, the disease is likely to be eradicated as long as the subsidy 
covers the cost of production, hence it should ensure universal demand. Thus, if the price equals the subsidy, then 
it is free to consumers and so eradication is possible in the perfect competitive market where the subsidy covers 
the entire cost of production and distribution to the consumers. In a case of monopoly market or monopolist with 
a constant marginal cost, setting the price equals to the subsidy will lead to eradication proper but the monopolist 
would be rambling future profit after eradication and run-out of business. Due to the above reason, the monopolist 
would always set the price little or more above the average cost of production depending on the profit motive of 
the monopolist, such that the price sets would always exceed the subsidy. Here even though there is subsidy the 
consumer still pays some amount to access vaccination or preventive care, then there will be no universal demand 
and no eradication to COVID-19.  
 Note that with subsidy, the monopolist faces an inelastic demand, which implies that, a larger 
change in price brings about a no or little change in quantity demanded of the preventive care of COVID-19. The 
monopolist gets higher profit by charging higher prices and since the consumers are constraint with the output of 
the monopolist, eradication will not be possible due to a positive price of vaccination or preventive care of COVID-
19 and no available substitute of preventive care of COVID-19 for the consumers. Again, since demand is also 
inelastic, then   the high rate of elasticity of prevalence will not be profitable for the monopolist to aid in the 
eradication of COVID-19 in the face of this pandemic. In a nutshell, eradication will be possible when the 
preventive care are free, treatment are free or at a subsidize rate (or affordable), adequate information flow about 
the COVID-19 prevalence rate. Above all, the government and public intervention should outweigh the private 
intervention in order to make COVID-19 eradication to be possible.  
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